CAMBRIAN BIOPHARMA
Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.
CAMBRIAN BIOPHARMA
Industry:
Biopharma Biotechnology Life Science
Founded:
2019-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
160 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Euro
Similar Organizations
Arbor Biotechnologies
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Bicara Therapeutics
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Omniome
Omniome engages in developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.
Current Advisors List
Current Employees Featured
Founder
Investors List
Future Ventures
Future Ventures investment in Series C - Cambrian Biopharma
SALT Fund
SALT Fund investment in Series C - Cambrian Biopharma
Alumni Ventures
Alumni Ventures investment in Series C - Cambrian Biopharma
Anthos Capital
Anthos Capital investment in Series C - Cambrian Biopharma
Apeiron Investment Group
Apeiron Investment Group investment in Series C - Cambrian Biopharma
infinitas capital group
infinitas capital group investment in Series C - Cambrian Biopharma
Kliwla Family Office AG
Kliwla Family Office AG investment in Series C - Cambrian Biopharma
Moore Capital
Moore Capital investment in Series C - Cambrian Biopharma
infinitas capital group
infinitas capital group investment in Series B - Cambrian Biopharma
Mike Novogratz
Mike Novogratz investment in Series B - Cambrian Biopharma
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-19 | Oviva Therapeutics | Cambrian Biopharma investment in Seed Round - Oviva Therapeutics | 11.5 M USD |
| 2021-06-23 | Vita Therapeutics | Cambrian Biopharma investment in Series A - Vita Therapeutics | 32 M USD |
| 2021-04-13 | Arcellx | Cambrian Biopharma investment in Series C - Arcellx | N/A |
| 2021-01-11 | Sensei Biotherapeutics | Cambrian Biopharma investment in Series B - Sensei Biotherapeutics | 30 M USD |
| 2020-10-07 | Sensei Biotherapeutics | Cambrian Biopharma investment in Series A - Sensei Biotherapeutics | 28.5 M USD |
Newest Events participated
More informations about "Cambrian Biopharma"
About - Cambrian Bio
Cambrian’s sourcing and development engine allows us to identify promising science, deploy capital and teams of drug development experts, and provide stewardship to advance new medicines that will lengthen healthspan. By …See details»
Cambrian Biopharma - Crunchbase Investor Profile & Investments
Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed …See details»
Cambrian Bio 2025 Company Profile: Valuation, …
Cambrian Bio General Information Description. Developer of a portfolio of medicines designed to target the causes of age-related diseases. The …See details»
Mission, Vision & Core Values of Cambrian Biopharma
Oct 12, 2024 The Cambrian Biopharma Mission, Vision & Core Values. Cambrian Biopharma is a cutting-edge biotechnology company dedicated to revolutionizing the pharmaceutical …See details»
Cambrian BioPharma - 2025 Company Profile - Tracxn
Mar 14, 2025 Cambrian BioPharma - Developer of medicines and therapies. Raised a total funding of $211M over 4 rounds from 22 investors. Founded by James Peyer in the year 2019. …See details»
Cambrian Biopharma CAM-7520 - lifespan.io
Cambrian Biopharma is a biotechnology company focused on developing treatments that target the underlying biology of aging to extend human healthspan. They aim to create a pipeline of …See details»
Cambrian Biopharma | Catalio Capital Management
Cambrian Biopharma is a clinical stage platform company focused on developing novel medicines that target the causes of aging and age-associated diseases such as cancer, heart disease, …See details»
Cambrian Biopharma - VentureRadar
Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed …See details»
Cambrian Biopharma Company Profile - Office Locations ... - Craft
Cambrian Biopharma $160 m in total funding,. See insights on Cambrian Biopharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Who Owns Cambrian Biopharma – CanvasBusinessModel.com
Oct 12, 2024 It sets the tone for how employees perceive their roles, responsibilities, and contributions to the organization. At Cambrian Biopharma, ownership is not just about who …See details»
Cambrian BioPharma - Raised $211M Funding from 22 investors
6 days ago Cambrian BioPharma has raised a total funding of $211M over 4 rounds from 22 investors. Investors include Shake and Bake Productions, Catalio Capital Management and 20 …See details»
Hear how Cambrian BioPharma is reinventing drug (and drug …
May 3, 2023 Cambrian BioPharma bills itself as a new pharmaceutical company with a revolutionary approach to developing and managing drug development. James Peyer, PhD, co …See details»
Cambrian secures $100M series C for Roivant-like approach to …
Oct 26, 2021 Cambrian Biopharma is on a mission to slow down the aging process and treat humans before they even develop cancer or Alzheimer's disease. Before the biotech can test …See details»
Cambrian Bio
NEW YORK , Nov. 4, 2022 /PRNewswire/ -- Cambrian BioPharma, a multi-asset longevity biotech, today announced that its CEO, James Peyer, has been selected as "BioTech …See details»
Cambrian Bio Launches Telos Biotech to Enable More Robust Cell …
Jun 27, 2023 The organization will develop Telovance ™, a novel recombinant protein delivered intracellularly during the ex-vivo manufacturing of CAR-T cells. ... SOURCE Cambrian …See details»
Cambrian Biopharma Closes $100 Million Series C to Advance
About Cambrian Biopharma Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in …See details»
Cambrian Biopharma Closes $100 Million Series C to Advance …
Nov 2, 2021 Cambrian Biopharma, a multi-asset longevity biotech, announced the close of an oversubscribed Series C financing, which raised $100 million.The financing was co-led by …See details»
Simplification for success: Rewiring the biopharma operating model
6 days ago Thirty-seven of them expect their organization to pursue a simplification effort over the next 12 months. Thirty-two respondents say they believe they need a significantly different …See details»
Cambrian Bio
Sep 14, 2022 NewYork, New York, September 14, 2022 - Cambrian BioPharma, a multi-asset longevity biotech, today announces its Scientific Advisory Board (SAB) and appointment of C. …See details»
Cambrian Bio
Oct 26, 2021 Cambrian BioPharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As …See details»